TORONTO--(BUSINESS WIRE)--BioPharma Services Inc. (BPSI) is pleased to announce that Brent Matthews has joined the company in the role of Chief Operating Officer. Brent brings to BioPharma extensive knowledge and experience in the areas of clinical and laboratory operations ranging from R&D, Bioanalytical Services, Quality Control and Quality Assurance and will provide operational leadership and support to the organization.
Brent is a progressive leader with over 30 years of experience in the pharmaceutical industry, having held senior roles including General Manager at Innopharm Inc., VP of Quality at Contract Pharmaceuticals Limited, Director of Bioanalytical Laboratory at Biovail, as well as Senior Manager R&D Compliance at Teva. Brent's management style includes focused mentoring and coaching techniques and real life application of extensive experience in process improvement and Lean.
BPSI’s Chief Executive Officer, Renzo DiCarlo stated: “We are very pleased to have Brent on board as our COO. He brings a wealth of experience to BioPharma in both Bioanalytical as well as Clinical Operations.”
About BioPharma Services Inc.
BioPharma Services Inc. is a Full-Service Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa clinical trials as well as Bioequivalence trials for international pharmaceutical companies worldwide. The company has clinical facilities both in the U.S.A. and in Canada with a total bed capacity of 250 with access to healthy volunteers, special populations and patients. Headquartered in Toronto, Canada, Bio Pharma’s services and capabilities also include support services such as GLP certified Laboratory, PK/Scientific and Regulatory Affairs, Bioanalysis, Biostatistical analysis, Medical Writing and Data Management.
For press release and other company information, please visit BioPharma Services Inc.’s web site at www.biopharmaservices.com